When it comes to targeted acne treatment, two ingredients come up consistently in both clinical research and skincare formulation: salicylic acid and tea tree oil. Here’s what the evidence actually says about each.
Salicylic acid
Salicylic acid is a Beta Hydroxy Acid (BHA) — an oil-soluble exfoliant that can penetrate into the pore lining, unlike water-soluble AHAs which work primarily on the skin surface. This makes it particularly effective for congested, acne-prone skin.
At concentrations of 0.5–2%, salicylic acid has been shown to reduce non-inflammatory acne lesions (blackheads and whiteheads) and support clearer pores with regular use. A review in the Journal of Clinical and Aesthetic Dermatology confirmed its efficacy as a keratolytic agent — meaning it helps break down the buildup of dead skin cells inside pores (Arif, 2015).
REAL SUPPORT contains 2% salicylic acid — the maximum concentration permitted for leave-on cosmetic products under EU Cosmetics Regulation.
Tea tree oil
Tea tree oil (Melaleuca alternifolia leaf oil) has been used in topical skincare for decades. A well-cited randomised controlled trial published in the Medical Journal of Australia found that a 5% tea tree oil gel was comparable to 5% benzoyl peroxide in reducing acne lesions, with fewer side effects such as dryness and peeling (Bassett et al., 1990).
More recent research has focused on its antimicrobial properties, which may help reduce the presence of acne-associated bacteria on the skin surface (Carson et al., 2006, Clinical Microbiology Reviews).
REAL SUPPORT contains 3% tea tree oil.
Why use them together?
Salicylic acid and tea tree oil work through different mechanisms — one exfoliates inside the pore, the other targets surface bacteria. Used together in a targeted spot treatment, they address two of the key factors in acne formation without the systemic side effects of prescription treatments.
Apply REAL SUPPORT directly to individual blemishes on clean skin. Use as needed — not all over the face.
Sources: Arif (2015), Journal of Clinical and Aesthetic Dermatology. Bassett et al. (1990), Medical Journal of Australia. Carson et al. (2006), Clinical Microbiology Reviews.
0 comments